WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6501 Infant (under 12 months) mortality rate: 392
GDP / capita (US$): 1'5561 Child (under 5 years) mortality rate: 552

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 12'100  11'777  11'458  11'144  10'837  8'396  7'215  5'141 
Births 418  414  410  406  401  323  314  277 
Surviving infants 399  394  390  385  379  292  246  245 
Pop. less than 5 years 1'928  1'941  1'945  1'899  1'786  1'676  1'439  1'061 
Pop. less than 15 years 5'090  5'054  5'028  4'966  4'843  3'909  3'591  2'468 
Female 15-49 years 3'048  2'927  2'804  2'698  2'621  1'993  1'555  1'131 

Number of reported case

(Click for retrospective incidence data for Rwanda)
Diphtheria 14 
Japanese encephalitis
Measles 10  17  75  31  121  2'095  8'970  80'402 
Mumps
Pertussis 177  16'189 
Polio* 24 
Rubella 15  50  172  62  36 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 10  18  103 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Rwanda)
Vaccine year result method % card seen                                                
BCG 2012  99  EPI   80  99  99*  99  99  99  81  57 
DTP1 2012  99  EPI   80  99  99*  99*  98  98  93 
DTP3 2012  98  EPI   80  98  99*  99*  97  97  90  57 
DTP4         
IPV1         
HepB_BD         
HepB3 2012  98  EPI   80  98  99*  99*  97  97 
Hib3 2012  98  EPI   80  98  99*  99*  97  97 
JapEnc         
MCV1          97  99  99*  95  95  57  55 
MCV2          77 
PCV1          99  99*  99*  98  98 
PCV3 2012  98  EPI   80  98  99*  99*  97  97 
Pol3 2012  98  EPI   80  98  99*  99*  93  93  90  58 
Rota1          99  99*  99* 
Rota_last          98  99*  99 
Rubella1          97 
TT2plus 2012  92  EPI   80  92  78  76  62  58  87 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Rwanda)
BCG 99  99  99  99  99  81  92 
DTP1 99  99  99  98  98  93  94 
DTP3 99  99  98  97  97  90  84 
HepB3 99  99  98  97  97 
HepB_BD
Hib3 99  99  98  97  97 
MCV1 98  97  97  95  95  74  83 
MCV2
PAB 90  85  85  85  85  81  85 
PCV3 99  99  98  97  97 
Pol3 99  99  98  93  93  90  83 
Rota_last 98  99  50 
YFV

Number of districts in the country 30  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 87
From 80 to 89% 13
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +2, +6 months; Yes
MR 9 months; Yes
Measles 15 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2017  2012-2017  2013-2017  2013-2017  2011-2015  2008-2012  2008 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 30  30  30  30  30  30  30 

System performance

Total Nº districts in country number 30  30  30  30  30  30  30 
Nº districts with DTP3 coverage >=80% number 30  30  30  18  29 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  60  97 
Nº districts with measles (MCV1) coverage >=95% number 16  19  26      12 
% of districts with MCV1 coverage >=95% From 0 to 100% 53  63  87      40 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 11  16  50  94  29  25 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.